Elevate Capital Advisors, LLC

SEC CIK: 0001909571
Latest filing: Jul 31, 2026

SEC filings (opens in a new tab)

DYN holding history

Dyne Therapeutics, Inc. in every 13F filed by Elevate Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DYN overview All 13F holders of DYN Full Q2 2026 holdings

Shares (Q2 2026): 20,435
Value: $453.9K
% of portfolio: 0.3%
Quarters held: 3; Since Q4 2025

Holdings of DYN by Elevate Capital Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	20,435	$453.9K	0.3%	−4,165−16.9%	Reduced	Holders
Q1 2026	24,600	$446.0K	0.3%	+486+2.0%	Added	Holders
Q4 2025	24,114	$471.7K	0.3%	+24,114	New	Holders